Status:

ACTIVE_NOT_RECRUITING

High-dose Intravenous Vitamin C for the Treatment of Severe Acute Pancreatitis

Lead Sponsor:

Ruijin Hospital

Collaborating Sponsors:

Shanghai Municipal Science and Technology Commission

Conditions:

Severe Acute Pancreatitis

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

This study is a prospective, randomized, double-blinded, parallel-controlled, multi-central clinical trial for patients with severe acute pancreatitis (SAP). Patients with SAP in the early stage (with...

Eligibility Criteria

Inclusion

  • Age ≥18 years
  • Time from onset of illness to enrollment is less than 7 days
  • Meet the 2012 Atlanta Guidelines SAP diagnostic criteria

Exclusion

  • SAP caused by tumors or ERCP
  • Pregnant or breastfeeding
  • Allergic to vitamin C
  • Use of other experimental drugs within the timeframe of this study
  • Chronic organs failure such as heart, liver, lung, or kidney before admission, with specific indicators being (chronic cardiovascular dysfunction requiring long-term mechanical hemodynamic support or inotropic drug support; chronic obstructive pulmonary disease requiring home oxygen therapy; chronic liver dysfunction at Child-Pugh Class C; chronic kidney disease with an estimated glomerular filtration rate (eGFR) of less than 60 mL/min/1.73 m² or serum creatinine greater than 150 μmol/L)
  • Immunosuppressed state, including malignant tumors, post-transplant status, long-term use of immunosuppressor (for at least 1 month before enrollment), AIDS, etc.
  • The patient and family are unwilling to sign the informed consent form
  • Body weight greater than 100kg
  • Urinary system stones

Key Trial Info

Start Date :

March 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2027

Estimated Enrollment :

388 Patients enrolled

Trial Details

Trial ID

NCT06897384

Start Date

March 1 2025

End Date

December 31 2027

Last Update

March 26 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital

Shanghai, Shanghai Municipality, China